Other sites
Search
Share
Cancer Institute NSW
Browse This Site Hide Full Menu

Cancer Institute NSW Board

There are currently ten members of the Cancer Institute NSW Board.

The Hon Morris Iemma BEc LLB

Chairperson of the Board of the Cancer Institute NSW

Mr Iemma served as a Member of Parliament in the NSW Legislative Assembly for 17 years 3 months from May 1991 until September 2008. He held a number of Ministerial portfolios including Premier, Treasurer, Minister for Health, Minister for Sport and Recreation, Minister for Public Works and Services, Minister for State Development and Minister Assisting the Premier on Citizenship. He has a BEc degree from the University of Sydney and an LLB from the University of Technology, Sydney.

Professor David Currow BMed MPH FRACP

Chief Cancer Officer and CEO

Professor Currow is Chief Cancer Officer and CEO of the Cancer Institute NSW. Prior to this he was the foundation Chief Executive Officer of Cancer Australia, the Australian Government's national cancer control agency. Professor Currow initially trained as a physician in internal medicine with sub-speciality training in palliative medicine and he completed a Master of Public Health exploring changes in the reported incidence of cancer unknown primary in New South Wales over a 25 year time period.

Former roles include foundation Director of the Nepean Cancer Care Centre, Sydney and Area Director of Palliative Services Wentworth Area Health Service, Sydney. Since 2000 he has held the Chair of Palliative and Supportive Services at Flinders University. He has published widely in palliative care journals and the general medical literature. He is a former president of the Clinical Oncological Society of Australia and a former president of Palliative Care Australia, the peak body for palliative care in the country.

Mr Keith Cox OAM NP

Mr Cox is a nurse practitioner in the oncology chemotherapy unit at Sydney's Royal Prince Alfred Hospital (RPA). He was authorised as a nurse practitioner in 2005 and prior to this he acted in a clinical nurse consultant role. He is a Senior Clinical Lecturer at the University of Sydney. Mr Cox has travelled to Nepal and Papua New Guinea to help set up oncology units and to train local nurses. He is also a member of the Cancer Nursing Society of Australia and Chair of their Winter Congress Committee.  He also works in other community areas including CanTeen, St Vincent de Paul and volunteering through his local parish. Mr Cox was awarded an OAM in 2007 for his services to nursing and community volunteer work.

Sally Goss MA, Grad Dip Nurs, RN

Ms Goss is currently a board member of the National Gynaecological Cancer Foundation and has previous board experience with Family Planning NSW, Mental Illness Education Australia and Petrea King's Quest for Life. Ms Goss's professional career has included working with BreastScreen NSW at both local and state level. At Family Planning NSW she worked in a range of clinical, research and management roles culminating in her appointment as Manager Clinical Services and Chief Nurse.

In recent years Ms Goss has worked closely with, and been a strong advocate for women living with gynaecological cancers having completed a research project and subsequently convening a fundraising group. She was awarded a Churchill Fellowship in 2009 travelling to Canada, USA and UK to examine differing models of psychosocial care.

Professor Peter Gunning BSc(Hons), PhD

Professor Gunning is the Head of the Oncology Research Unit in the Department of Anatomy at the University of New South Wales. His research is focussed on the development of new therapeutic strategies for the treatment of childhood cancer. These strategies target the skeleton of the cancer cell and build on the principles of cell architecture that Professor Gunning's group has discovered over the last 20 years.

Professor Gunning has published over 100 primary research articles and has recently edited the first book devoted to his field of research. Previous appointments have included leadership roles as Chair of the Division of Research at The Children's Hospital at Westmead, Chair of the Westmead Research Hub Executive and the Founding Chair of Bio-Link, a company established by the NSW Government to support commercialisation of biomedical intellectual property.

Dr Paul Moy BA (Hons-Ec), Dip Ed, PhD(Ec)

Dr Moy is Global Head of Infrastructure and Private Equity, UBS Global Asset Management, based in London and has 21 years of investment industry experience. He has extensive experience in banking and principal investment internationally, as well as public policy in the early part of his career. Dr Moy is an experienced company director of both private and public companies, as well as non-profit organisations.

Professor Michael Solomon MBBCh, BAO, MSc, FRACS

Professor Michael Solomon is a consultant surgeon and Academic Head of the Department of Colorectal Surgery at the Royal Prince Alfred Hospital in Sydney. He is a Clinical Professor of Surgery and Director of Colorectal Research, both for Royal Prince Alfred Hospital and the University of Sydney and is a past the President of the Colorectal Surgical Society of Australia & New Zealand (CSSANZ). He is on the editorial board of DCR, Colorectal Disease & Int J Colorectal Diseases.

Professor Solomon has published over 192 papers and obtained over 9 million dollars in peer reviewed research grants.  He is the Founding Director and Head of the Surgical Outcomes Research Centre (SOuRCe) at the University of Sydney which was established as a multidisciplinary, academic research unit dedicated to the advancement of evidence-based surgical practice through the conduct of outcomes-orientated surgical research. Professor Solomon's surgical expertise is in multi-disciplined complex pelvic surgery for advanced and recurrent malignancy, inflammatory bowel disease and pelvic floor disorders as well as laparoscopic colorectal surgery. His current research interests lie in developing maximally invasive techniques for advanced pelvic malignancy, clinical trials of minimally invasive colorectal surgery and the assessment and performance of randomised and alternative clinical trial designs for surgical operations.

Mr John Stubbs BA Dip Acct

Mr Stubbs holds government positions at both board and committee levels. He is a survivor of Leukaemia and an active representative of cancer consumers. He is an Honorary Associate of the University of Sydney, School of Medicine and member of the Radiation Oncology Workforce Committee. Mr Stubbs is the Australian Consumer representative on the International Colon Cancer Familial Register funded through the National Cancer Institute (NCI) in the US. He has contributed to a number of booklets, including Cancer how are you travelling; research papers; an editor of the Asia Pacific Journal of Clinical Oncology; edited consumer booklets for the Cancer Council; and is an active contributor to Government policy on cancer, cancer services and the value of consumer involvement.

Ms Lucy Turnbull AO LLB MBA

Ms Turnbull is a businesswoman and company director. She was Lord Mayor of the City of Sydney from 2003 to 2004 and Deputy Lord Mayor from 1999 to 2003. Ms Turnbull was Deputy Chair of the COAG Reform Council's Cities Expert Advisory Panel. She chairs ASX listed Prima Biomed Limited, and is a board member of the Australian Technology Park. She is active in the not-for-profit sector and is a board member of the US Studies Centre at the University of Sydney, the Biennale of Sydney and the Redfern Foundation. In 2011 she was made an Officer of the Order of Australia for her services to the community, local government ad business. In 2012 she was awarded an honorary doctorate in business administration from the University of New South Wales.

Professor Robyn Ward MBBS PhD FRACP

Professor Ward is the Clinical Associate Dean, Prince of Wales Clinical School, University of NSW. She is a specialist medical oncologist at Prince of Wales Hospital, Sydney and also leads the adult cancer research program in the Lowy Cancer Research Centre. Amongst other roles, Robyn serves as a member fo the Commonwealth's Pharmaceutical Benefits Advisory Committee, and was appointed in 2009 as Chair of the Medical Services Advisory Committee. She is also a member of the National Health and Medical Research Council and Chair of its Human Genetics Advisory Committee.